Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Soloway

Showing results (171-180 of 252) with videos related to

Pageof 26
Sort By:
The Prostate|March 15, 2012
Pathological findings at radical prostatectomy in patients initially managed by active surveillance: a comparative analysisViacheslav Iremashvili, Murugesan Manoharan, Daniel L Rosenberg, et al.
European Urology|August 21, 2010
Liver transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step descriptionGaetano Ciancio, Javier Gonzalez, Samir P Shirodkar, et al.
The Journal of Urology|June 18, 2004
Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancerPaul D Sved, Pablo Gomez, M Manoharan, et al.
European Urology|June 30, 2009
Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experienceGaetano Ciancio, Murugesan Manoharan, Devendar Katkoori, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India|March 2, 2013
Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completionAhmed Eldefrawy, Mark S Soloway, Devendar Katkoori, et al.
Urology|February 19, 2008
Trends in Gleason score: concordance between biopsy and prostatectomy over 15 yearsAyyathurai Rajinikanth, Murugesan Manoharan, Cynthia T Soloway, et al.
European Urology|March 27, 2012
Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocolsViacheslav Iremashvili, Lisét Pelaez, Murugesan Manoharan, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 16, 2011
Oncological and functional outcomes following open radical prostatectomy: how patients may achieve the "Trifecta"?Elie Antebi, Ahmed Eldefrawy, Devendar Katkoori, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate diseaseEdna Gordian, Kavitha Ramachandran, Isildinha M Reis, et al.
The Journal of Biological Chemistry|June 27, 2002
Regulation of hyaluronidase activity by alternative mRNA splicingVinata B Lokeshwar, Grethchen L Schroeder, Robert I Carey, et al.
Pageof 26

Showing results (171-180 of 252) with videos related to

Sort By:
Pageof 26
The Prostate|March 15, 2012
Pathological findings at radical prostatectomy in patients initially managed by active surveillance: a comparative analysisViacheslav Iremashvili, Murugesan Manoharan, Daniel L Rosenberg, et al.
European Urology|August 21, 2010
Liver transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step descriptionGaetano Ciancio, Javier Gonzalez, Samir P Shirodkar, et al.
The Journal of Urology|June 18, 2004
Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancerPaul D Sved, Pablo Gomez, M Manoharan, et al.
European Urology|June 30, 2009
Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experienceGaetano Ciancio, Murugesan Manoharan, Devendar Katkoori, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India|March 2, 2013
Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completionAhmed Eldefrawy, Mark S Soloway, Devendar Katkoori, et al.
Urology|February 19, 2008
Trends in Gleason score: concordance between biopsy and prostatectomy over 15 yearsAyyathurai Rajinikanth, Murugesan Manoharan, Cynthia T Soloway, et al.
European Urology|March 27, 2012
Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocolsViacheslav Iremashvili, Lisét Pelaez, Murugesan Manoharan, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 16, 2011
Oncological and functional outcomes following open radical prostatectomy: how patients may achieve the "Trifecta"?Elie Antebi, Ahmed Eldefrawy, Devendar Katkoori, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate diseaseEdna Gordian, Kavitha Ramachandran, Isildinha M Reis, et al.
The Journal of Biological Chemistry|June 27, 2002
Regulation of hyaluronidase activity by alternative mRNA splicingVinata B Lokeshwar, Grethchen L Schroeder, Robert I Carey, et al.
Pageof 26